To include your compound in the COVID-19 Resource Center, submit it here.

Shin Nippon Biomedical Laboratories, Sosei deal

Shin Nippon signed a non-binding letter of intent with Sosei to negotiate a deal to co-develop products based on

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE